SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001580642-18-000853
Filing Date
2018-02-12
Accepted
2018-02-12 17:20:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G kalvista13g.htm SC 13G 42539
  Complete submission text file 0001580642-18-000853.txt   44511
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Subject) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: SC 13G | Act: 34 | File No.: 005-88797 | Film No.: 18597624
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE INTERNATIONAL PLACE SUITE 3510 BOSTON MA 02110
Business Address ONE INTERNATIONAL PLACE SUITE 3510 BOSTON MA 02110 877-771-3836
EVENTIDE ASSET MANAGEMENT, LLC (Filed by) CIK: 0001442891 (see all company filings)

IRS No.: 262508416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G